Corrigendum: Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer

Hui-Wen Yang1,2, Yan Lan1, An Li1,2

  • 1Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, Jiangsu, China.

Frontiers in Pharmacology
|November 29, 2024
PubMed

Insights

This study corrects a previous article DOI. The corrected DOI is 10.3389/fphar.2023.1288883, ensuring proper citation and access to the research findings.

Area of Science:

  • Pharmacology and Toxicology